Moore Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,000
| Closed | -$2.13M | – | 457 |
|
|
2024
Q2 | $2.13M | Buy |
+20,000
| New | +$2.13M | 0.04% | 235 |
|
|
2023
Q4 | – | Sell |
-6,100
| Closed | -$790K | – | 447 |
|
|
2023
Q3 | $790K | Sell |
6,100
-5,900
| -49% | -$764K | 0.01% | 255 |
|
|
2023
Q2 | $1.49M | Buy |
12,000
+9,000
| +300% | +$1.12M | 0.03% | 248 |
|
|
2023
Q1 | $439K | Buy |
+3,000
| New | +$439K | 0.01% | 301 |
|
|
2022
Q3 | – | Sell |
-45,829
| Closed | -$7.15M | – | 704 |
|
|
2022
Q2 | $7.15M | Sell |
45,829
-114,771
| -71% | -$17.9M | 0.19% | 111 |
|
|
2022
Q1 | $25M | Buy |
+160,600
| New | +$25M | 0.64% | 19 |
|
|
2021
Q1 | – | Sell |
-169,449
| Closed | -$28M | – | 713 |
|
|
2020
Q4 | $28M | Buy |
169,449
+86,995
| +106% | +$14.4M | 0.31% | 36 |
|
|
2020
Q3 | $11.8M | Buy |
+82,454
| New | +$11.8M | 0.22% | 80 |
|
|
2016
Q1 | – | Sell |
-35,000
| Closed | -$4.92M | – | 269 |
|
|
2015
Q4 | $4.92M | Buy |
+35,000
| New | +$4.92M | 0.15% | 133 |
|